Great Novel Therapeutics Biotech & Medicals
7427
Rank in Stocks
#19843
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Share Price
$1.82
Last synced: 2026-11-10
Market Cap
$96.46M
Change (1 day)
-0.33%
Change (1 year)
52.70%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Great Novel Therapeutics Biotech & Medicals (7427)
Category
Healthcare
Operating Margin for Great Novel Therapeutics Biotech & Medicals (7427)
Operating Margin as of November 2026 TTM: -1,886.11%
According to Great Novel Therapeutics Biotech & Medicals's latest financial reports, its current operating margin (TTM) is -1,886.11%. At the end of 2025 the company had an operating margin of -8,260.91%.
Operating Margin history for Great Novel Therapeutics Biotech & Medicals from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1,886.11% | -77.17% |
| 2025 | -8,260.91% | 23.57% |
| 2024 | -6,685.28% | 392.61% |
| 2023 | -1,357.11% | -87.24% |
| 2022 | -10,636.67% | 83.49% |
| 2021 | -5,796.98% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.02% |
US
|
|
| -149.01% | -99.92% |
US
|
|
| 25.57% | -100.01% |
AU
|
|
| 31.23% | -100.02% |
BE
|
|
| 29.35% | -100.02% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Great Novel Therapeutics Biotech & Medicals's operating margin
What is Great Novel Therapeutics Biotech & Medicals's operating margin?
Great Novel Therapeutics Biotech & Medicals's operating margin is -1,886.11%, as of Nov 2026.
What was Great Novel Therapeutics Biotech & Medicals's operating margin in 2025?
In 2025, Great Novel Therapeutics Biotech & Medicals's operating margin was -8,260.91%, compared with -6,685.28% in 2024.
How has Great Novel Therapeutics Biotech & Medicals's operating margin changed since 2020?
From 2020 to 2025, Great Novel Therapeutics Biotech & Medicals's operating margin was highest in 2020 (0.00%) and lowest in 2022 (-10,636.67%).
How does Great Novel Therapeutics Biotech & Medicals's operating margin compare with similar companies?
Great Novel Therapeutics Biotech & Medicals's operating margin (-1,886.11%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.